Childrens Cetirizine Hydrochloride Hives Relief Solution
Product Images NDC 58602-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Childrens Cetirizine Hydrochloride Hives Relief (NDC 58602-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1 mg/mL (120 mL Bottle))

Package Label-principal Display Panel (1 mg/mL (120 mL Bottle))
This product is an oral solution antihistamine for children that relieves itching due to hives. It is not meant to prevent hives or allergic reactions from occurring. It should be taken with the enclosed dosing cup and should not be taken more than once daily for adults and children six years and over. It warns against driving a vehicle or operating machinery while on this product as drowsiness may occur. If symptoms do not improve after seven days or last more than six weeks, contact a doctor. It is manufactured by Aurobindo Pharma Limited and distributed by AUROHEALTH LLC in the USA.*
FDA Label Image

Package Label-principal Display Panel (1 mg/mL Carton (120 mL))

Package Label-principal Display Panel (1 mg/mL Carton (120 mL))
This is a drug information sheet for Children's Cetirizine Hydrochloride Oral Solution USP, used for relief of itching due to hives in children over six years old. The solution contains 1 mg/mL of Cetirizine Hydrochloride. It is necessary to consult a professional before consuming the solution during pregnancy or breastfeeding. The inactive ingredients include cherry mint flavor, purified water, and others. The product is packed in 120 ml bottles, and the recommended dose should not exceed one teaspoonful (5ml). If an individual experiences symptoms of anaphylactic shock or overdose, they should contact a healthcare professional immediately.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.